Thymidine kinase 1 — Drug Target

All drugs that target Thymidine kinase 1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nucleoside analog

Phase 3 pipeline (1)

• Trifluridine-tipiracil · The Methodist Hospital Research Institute · Nucleoside analog · Oncology
  Trifluridine-tipiracil is a thymidine kinase 1 inhibitor that also has a thymidylate synthase inhibitor component, which works by interfering with DNA synthesis in cancer cells.